Genetics of Sudden Cardiac Arrest

Solving the mystery of sudden cardiac arrest in the young and healthy

When a young mother and former Division 1 athlete has a sudden cardiac arrest at age 27, Ohio State's heart team investigate the underlying cause

By Melissa Weber, Contributing Writer School of Health & Rehabilitation Sciences

Heart patient Shayna Hemming sitting on the floor in her living room playing with her two kids and husbandShayna (Harmon) Hemming was an outstanding athlete in high school, lettering in basketball and softball. A 2016 graduate of Teays Valley High School, south of Columbus, Ohio, Hemming holds the record for the most points scored in basketball for any player in Pickaway County. She attended the University of Akron on a Division 1 basketball scholarship, and by November 2024, Hemming was busy living her dream. After graduating from college, she returned to her hometown and married her high school sweetheart. Two healthy children followed.

And then, an unexpected sudden sudden cardiac arrest at age 27 changed everything Hemming thought she knew about her own body.

The day before her emergency, she remembers, they were enjoying Thanksgiving dinner at her parents’ house just two streets away from where she and her husband live. She remembers taking her son back to the house later that night for more pie. But after that, she only knows what her family has told her about the next morning and the critical days that followed.

Around 4 a.m., her 2-year-old son Greyson came to his parent’s bedroom. Shayna told him to lay down, and minutes later, Trevor Hemming heard Shayna struggling to breathe. Unable to wake her, he felt for a pulse but couldn’t find one.

“Greyson and Trevor are my heroes,” Hemming says.

While Trevor kept Shayna alive with CPR, he called 911 and contacted Shayna’s parents. They rushed to the house and cared for Greyson and 5-month-old daughter Callen while paramedics arrived. Hemming’s father posted a message to friends and family on Facebook: “Please pray for our family.”

Later, people would tell Hemming they prayed not knowing who was ill. “They said, ‘Well it can’t be Shayna. She’s the healthy one,’” she recalls. “It was a shock to everyone.”

After Hemming was stabilized by paramedics, she was rushed to a nearby hospital and then transferred to The Ohio State University Wexner Medical Center Richard M. Ross Heart Hospital.

There, cardiologists and other specialists assembled to seek one answer: Why does a young, healthy person like Hemming have a cardiac arrest?

Read the full article here

Featured Publications

Doug Lewandowski

Increased CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress that Suppresses Gene Programs for Remodeling and Enables Rescue by Gene Transfer.

E. Douglas, Lewandowski, PhD

Circulation Research 

This study found that CPT1a, a key enzyme involved in cardiac metabolism, plays a protective role in heart failure. In mouse models, loss of CPT1a worsened cardiac dysfunction, while increasing its expression improved heart function and reversed established disease. The findings suggest that enhancing CPT1a activity could be a promising therapeutic approach for treating heart failure.

Read on PubMed

Mahmood Khan

Safety and Engraftment of Aligned Cardiac Patches Loaded with hiPSC-CMs in a Large Animal Model of Myocardial Infarction

Mahmood Khan, MPharm, PhD

Theranostics

This study evaluated the safety and therapeutic potential of engineered cardiac patches containing aligned human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) in a large-animal model of myocardial infarction. The patches successfully engrafted onto the heart, improved cardiac function, promoted vascularization, and did not cause significant adverse events such as arrhythmias or tumor formation. These findings support the feasibility of using aligned stem cell–based cardiac patches as a regenerative therapy for repairing damaged myocardium after heart attack and provide important preclinical evidence for future clinical translation.

Read on PubMed

Onur Kanisicak

Pulmonary fibroblast activation during Aspergillus fumigatus infection enhances lung defense via immunomodulation and tissue remodeling

Onur Kanisicak, PhD, Michael Tranter, PhD, & Jose P. Guirao Abad, PhD

Nature Communications

This study investigated how pulmonary fibroblasts respond to infection with Aspergillus fumigatus, a major cause of invasive fungal pneumonia. Using lineage tracing, fibroblast ablation, and single-cell RNA sequencing in mouse models, the authors found that activated fibroblasts acquire immunomodulatory and tissue-remodeling functions that help limit fungal spread and lung damage. Depletion of these activated fibroblasts led to worse infection, increased tissue injury, and severe pulmonary hemorrhage, demonstrating that fibroblasts play a protective role in coordinating host defense. These findings highlight the importance of the lung stromal compartment as an active contributor to immunity during invasive fungal infection.

Read on PubMed

Daniel Gallego-Perez

Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injury

Daniel Gallego-Perez, PhD, Tatiana Cuellar-Gaviria, PhD, Natalia Higuita-Castro, PhD & Ana Salazar-Puerta, PhD

Science Advances

This study developed a nonviral gene-delivery approach called vasculogenic tissue nanotransfection (TNT) to improve recovery after peripheral nerve injury. By delivering a combination of vasculogenic transcription factors (Etv2, Fli1, and Foxc2), TNT reprogrammed local cells to promote blood vessel formation, creating a more supportive environment for nerve regeneration. In mouse models of nerve injury and nerve graft repair, TNT treatment increased vascularization, enhanced axonal regrowth and myelination, and significantly improved functional outcomes such as grip strength and muscle contractility. These findings suggest that vasculogenic TNT could serve as a clinically translatable adjunct therapy to enhance nerve repair and functional recovery after peripheral nerve injury.

Read on PubMed

 

Winter 2026

Winter 2026 Publications